Clinical study of in vivo optic imaging of breast cancer using diffuse optic spectroscopy

Clinical study of in vivo optic imaging of breast cancer using diffuse optic spectroscopy - Breast cancer imaging using diffuse optic spectroscopy

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011888

Enrollment

100

Registered

2013-09-29

Start date

2011-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

To measure optical parameters of breast cancer using optical device as well as conventional imaging devices on treatment. The aim of this prospective study was to evaluate diagnostic performance of s

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients aged older than 18 years who had 1) newly diagnosed biopsy-proven breast cancer, 2) had clinical stage T1c-4, N0-2 primary breast cancer according to TNM classification 6th edition, 3) planned to undergo at least 4 cycles of chemotherapy were eligible for a prospective TR-DOSI chemotherapy monitoring study.

Exclusion criteria

Exclusion criteria: Exclusion criteria were the following; pregnancy, prior treatment of breast cancer, bilateral breast cancer, or ineligibility of surgery.

Design outcomes

Primary

Measure	Time frame
(1)Rate of detection of early-stage breast cancer (2)Rate of clinicopathologic response (pCR) in the setting of neoadjuvant chemotherapy	—

Secondary

Measure	Time frame
(3)Disease-free survival (4)Overall survival	—

Countries

Japan

Contacts

Public ContactShigeto UEDA

International medical center, saitama medical university Department of breast oncology

syueda@saitma-med.ac.jp81-42-984-4670

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026